[Optimising the management of anaemia of renal origin: what benefits for the patient?].
Solignac
Marie
M
D000740:Anemia / Q000209:etiology* / Q000628:therapy*; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use*; D005602:France; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D010347:Patient Care Planning; D011379:Prognosis
D004921:Erythropoietin